Literature DB >> 24385111

Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemia.

Xishan Zhu1, Ziying Lin, Jing Du, Xu Zhou, Lawei Yang, Gang Liu.   

Abstract

Accumulating data indicate that cancer stem cells play an important role in tumorigenesis and are underlying cause of tumor recurrence and metastasis, specifically in chronic myeloid leukemia (CML). We aim to detect the miRNAs that are correlated with the cancer stem cells in CML to provide theoretical basis for clinical application. We first analyzed microRNA expression profiles of CML leukemia patients compared with normal controls by microarray analysis and validated the results by real-time PCR. A single microRNA signature classified CML from normal was detected. We also determined the absolute copy numbers of these three microRNAs in normal adults. The results showed that three microRNAs (miR-150, miR-23a, and miR-130a) were identified to significantly decrease in expanded 38 CML patients compared with 90 normal controls. Molecular and statistical analysis showed that the decreased microRNAs were significant in clinical analysis. All these results indicated that those three microRNAs could act as a tumor suppressor and their decreased expression might be one of the causes of leukemia. Accordingly, clarifying their regulatory mechanisms might delineate their potentials as drug targets of gene therapy for CML.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24385111     DOI: 10.1007/s11010-013-1958-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

1.  A microRNA array reveals extensive regulation of microRNAs during brain development.

Authors:  Anna M Krichevsky; Kevin S King; Christine P Donahue; Konstantin Khrapko; Kenneth S Kosik
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

2.  Regulation by bisoprolol for cardiac microRNA expression in a rat volume-overload heart failure model.

Authors:  Xinrong Li; Xiaofeng Zhang; Tingzhong Wang; Chaofeng Sun; Tianbo Jin; Hua Yan; Jiayi Zhang; Xiaolan Li; Tingting Geng; Chao Chen; Aiqun Ma; Shanqu Li
Journal:  J Nanosci Nanotechnol       Date:  2013-08

3.  Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs.

Authors:  Yingqing Sun; Seongjoon Koo; Neill White; Eigen Peralta; Christine Esau; Nicholas M Dean; Ranjan J Perera
Journal:  Nucleic Acids Res       Date:  2004-12-22       Impact factor: 16.971

4.  MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10).

Authors:  Cong Cheng; Weiguang Li; Zheng Zhang; Shohei Yoshimura; Qinyu Hao; Chi Zhang; Zhao Wang
Journal:  J Biol Chem       Date:  2013-04-01       Impact factor: 5.157

5.  A regulatory role for microRNA 33* in controlling lipid metabolism gene expression.

Authors:  Leigh Goedeke; Frances M Vales-Lara; Michael Fenstermaker; Daniel Cirera-Salinas; Aranzazu Chamorro-Jorganes; Cristina M Ramírez; Julie A Mattison; Rafael de Cabo; Yajaira Suárez; Carlos Fernández-Hernando
Journal:  Mol Cell Biol       Date:  2013-04-01       Impact factor: 4.272

6.  Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression.

Authors:  Jian Zhang; Dan Zhang; Guo-Qing Wu; Zhi-Ying Feng; Sheng-Mei Zhu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2013-06

7.  Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants.

Authors:  A Janowska-Wieczorek; M Majka; L Marquez-Curtis; J A Wertheim; A R Turner; M Z Ratajczak
Journal:  Leukemia       Date:  2002-06       Impact factor: 11.528

8.  Impaired immunomodulatory function of chronic myeloid leukemia cancer stem cells and the possible mechanism involved in it.

Authors:  Zhu Xishan; Zhou Xinna; He Baoxin; Ren Jun
Journal:  Cancer Immunol Immunother       Date:  2012-11-21       Impact factor: 6.968

9.  Intermittent exposure of primitive quiescent chronic myeloid leukemia cells to granulocyte-colony stimulating factor in vitro promotes their elimination by imatinib mesylate.

Authors:  Heather G Jørgensen; Mhairi Copland; Elaine K Allan; Xiaoyan Jiang; Allen Eaves; Connie Eaves; Tessa L Holyoake
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

10.  microRNA target predictions across seven Drosophila species and comparison to mammalian targets.

Authors:  Dominic Grün; Yi-Lu Wang; David Langenberger; Kristin C Gunsalus; Nikolaus Rajewsky
Journal:  PLoS Comput Biol       Date:  2005-06-24       Impact factor: 4.475

View more
  18 in total

1.  Primary analysis and screening of microRNAs in gastric cancer side population cells.

Authors:  Hai-Hong Zhang; Guo-Li Gu; Xiang-Yang Zhang; Feng-Zhi Li; Li Ding; Qin Fan; Ran Wu; Wei Shi; Xin-Yan Wang; Lin Chen; Xue-Ming Wei; Xiao-Ying Yuan
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Diverse microRNAs with convergent functions regulate tumorigenesis.

Authors:  Min-Yan Zhu; Wei Zhang; Tao Yang
Journal:  Oncol Lett       Date:  2015-12-09       Impact factor: 2.967

Review 3.  Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.

Authors:  Danilo Perrotti; Giovannino Silvestri; Lorenzo Stramucci; Justine Yu; Rossana Trotta
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

Review 4.  New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia.

Authors:  Saeid Shahrabi; Shirin Azizidoost; Mohammad Shahjahani; Fakher Rahim; Ahmad Ahmadzadeh; Najmaldin Saki
Journal:  Tumour Biol       Date:  2014-09-19

Review 5.  Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways.

Authors:  Ian A MacDonald; Nathaniel A Hathaway
Journal:  Immunol Cell Biol       Date:  2014-12-23       Impact factor: 5.126

6.  RNAi-mediated knockdown of MCM7 gene on CML cells and its therapeutic potential for leukemia.

Authors:  Liang Tian; Juan Liu; Guo-Hua Xia; Bao-An Chen
Journal:  Med Oncol       Date:  2017-01-05       Impact factor: 3.064

7.  The malignancy suppression role of miR-23a by targeting the BCR/ABL oncogene in chromic myeloid leukemia.

Authors:  Z Xishan; L Xianjun; L Ziying; C Guangxin; L Gang
Journal:  Cancer Gene Ther       Date:  2014-09-12       Impact factor: 5.987

8.  High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.

Authors:  Xiao-Wen Zhang; Ning Liu; Sheng Chen; Ye Wang; Zhao-Xiong Zhang; Yuan-Yuan Sun; Guang-Bin Qiu; Wei-Neng Fu
Journal:  Diagn Pathol       Date:  2015-04-03       Impact factor: 2.644

9.  MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation.

Authors:  Yuhuang Li; Kishore B Challagundla; Xiao-Xin Sun; Qinghong Zhang; Mu-Shui Dai
Journal:  Oncotarget       Date:  2015-01-20

10.  MicroRNA profiling in Muc2 knockout mice of colitis-associated cancer model reveals epigenetic alterations during chronic colitis malignant transformation.

Authors:  Yonghua Bao; Yongchen Guo; Zexin Li; Wenfeng Fang; Yiqiong Yang; Xuhan Li; Zhuangzhuang Li; Bowen Xiong; Zhiguo Chen; Jianguo Wang; Kang Kang; Deming Gou; Wancai Yang
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.